SCHEMBL6175530

SCHEMBL6175530

CC(c1ccnc(NS(N)(=O)=O)c1)C1NC(=O)N(c2ccc(S(=O)(=O)C(F)(F)F)cc2)C1=O

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 3/20 0.37
HRH4 Q9H3N8 2/20 0.32
LMNA P02545 1/20 0.32
TRPV3 Q8NET8 2/20 0.31
KDM4E B2RXH2 1/20 0.31
POLB P06746 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6173894 0.92 IGF1R (0.37) IGF1RHRH4LMNATRPV3SMN1; SMN2
SCHEMBL6172718 0.90 IGF1R (0.36) IGF1RHRH4LMNATRPV3
SCHEMBL6174748 0.87 IGF1R (0.43) IGF1R
SCHEMBL6173577 0.86 IGF1R (0.39) IGF1RHRH4LMNATRPV3SMN1; SMN2
SCHEMBL6175063 0.84 IGF1R (0.38) IGF1RLMNATRPV3KDM4E
SCHEMBL6175008 0.84 IGF1R (0.39) IGF1RHRH4LMNATRPV3SMN1; SMN2
SCHEMBL6175142 0.84 IGF1R (0.38) IGF1RHRH4LMNATRPV3SMN1; SMN2
SCHEMBL6174486 0.83 IGF1R (0.38) IGF1RHRH4LMNATRPV3SMN1; SMN2
SCHEMBL6175377 0.82 IGF1R (0.35) IGF1RTRPV3
SCHEMBL6172184 0.82 NPC1 (0.39) IGF1RLMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed